Progress Notes by Lehigh Valley Health Network
Imi!fVALLEY 
HOSPI'D\L 
In This Issue ... 
Director of 
Telecom N11111ed 
• Page 3 
News from Aflinity 
• Page 3 
News from LVDI 
• Page 4 
. HAMIS LastWord 
Classes 
• Page 5 
Epilqsy Patients 
Needed for Study 
• Page 5 
Help Your Patients 
Stop Smoking 
• Page 6 
Health Network 
lAboratories News 
• Pages 15 & 16 
P & T Highlights 
• Pages 17-20 
Self-Assessment 
Test for Skiff 
Physicians 
• Pages 21 & 22 
Observation Le11els 
Policy 
• Pages 23-25 
Medical Staff 
Progress Notes Volume 7. Number 2 February. 1995 
From the 
President 
It is both a great 
honor and a great 
challenge to serve as President of the 
Medical Staff. The honor lies in the 
privilege of representing our enormously 
talented medical staff to the hospital 
administration and board. The challenge 
lies in identifying the collective conscience 
and consensus of our diverse medical staff 
in the crucial areas of governship, policy, 
and medical staff development. 
To that end, I would encourage 
information sharing among us at many 
levels. It first and foremost should occur 
at our division and department meetings 
where tough issues need to be discussed, 
debated and resolved. E-mail and formal 
letters to me are helpful in keeping me 
informed of medical staff concerns. 
I will be meeting with our chairs, division 
and section chiefs, as well as past-
Presidents of the medical staff over the 
next several weeks to solicit their counsel 
and advice on medical staff issues. This 
will culminate in a draft of medical staff 
goals for 1995 and 1996 which I will 
present at the March medical staff 
meeting. 
Another level of information sharing is in 
the area of health care reform. This is a 
particularly important area as it will impact 
each of our lives, no matter what our 
specialty, in the very near future. A 
number of special lectures have already 
been given at Lehigh Valley Hospital 
although nearly all were poorly attended 
by our staff. I will be giving out special 
notices when future sessions are held in 
order to allow more of our staff to attend. 
At yet another level, I welcome you to 
attend the Medical Staff/Administrative 
Exchange Sessions held monthly. The 
goal of these sessions is to encourage the 
mutual exchange of information between 
members of the medical staff and the 
senior management in an informal and 
relaxed atmosphere. The format is simple. 
The first half hour is dedicated to 
nutrition; wine, cheese and crackers will 
be served. Joke telling is strongly 
encouraged. The remainder of the session 
is devoted to a roundtable discussion on 
topics from the floor which arise 
spontaneously or in pre-submitted 
questions to me during the month. The 
sessions are held from 5:30 to 7:30p.m on . 
the third Thursday of the month, on the 
first floor of the John and Dorothy Morgan 
Cancer Center, in Conference Room 1, 
Side B. For the remainder of the year, 
sessions will be held on March 16, April 
20, May 18, June 15, July 20, August 17, 
September 21, October 19, November 16 
and December 21. Pre-registration is 
requested as space is limited to 40 people. 
For more information, please call Janet M. 
Seifert, Physician Relations, at 402-9853. 
Continued on Page 2 
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Herbert "Chuck" Hoover, Jr., M.D., 
surgical oncologi~ from Massachusetts 
General Hospital in Boston, and associate 
professor of surgery at Harvard Medical 
School, has been named the new 
Chairperson of the Department of Surgery at 
Lehigh Valley Hospital. He will be joining 
us in March of this year. Chuck received 
his undergraduate degree at Kansas State 
College at Pittsburg and his M.D. degree at 
University of Kansas School of Medicine. 
He did his general surgical residency 
training at the MGH in Boston and 
completed a fellowship at the National 
Cancer Institute. A fellow of the American 
College of Surgeons, Dr. Hoover is also a 
member of its Commission on Cancer and 
currently serves on the editorial board for 
Vaccine Research Review, Archives of 
Surgery, Journal of National Cancer 
Institute, Cancer Research, The New 
England Journal of Medicine, and The 
Journal of Clinical Oncology. Dr. Hoover 
has earned a national reputation for his 
expertise in highly complex and specialized 
surgical oncological procedures. He is 
respected for his devotion to patient care and 
his commitment to medical education, and 
looks forward to a long, productive and 
rewarding relationship with our own highly 
talented and respected surgical staff. 
Our heartfelt thanks go to Walt Okunski, 
who has selflessly served for nearly three 
years as interim chair of Surgery during 
search proceedings. Walt has devoted 
thousands of hours to serving the needs of 
the Department of Surgery and has been of 
enormous help in the search process for Dr. · 
Hoover. We will forever be in his debt. 
Many thanks to the 148 members of the 
medical staff who participated in the 
Physician Satisfaction Survey. This survey 
will become a powerful tool to identify areas 
of strengths and weaknesses in our 
organization. Four areas have been 
identified for their strength and have been 
awarded letters of commendation. They aie 
Lehigh Magnetic Imaging Center, the 
caiwac Catheterization Laboratory, the Bum 
Unit, and Biomedical Photography. Kudos ( 
to the medical directors and staff that have 
made those areas so successful in the minds 
of the physicians they serve. Areas of 
physician dissatisfaction will be targeted for 
special attention in ensuing weeks. 
A number of physicians, nurses and 
administrators continue to labor over the 
functional plan forth~ hospital. The· eight 
core processes of patient care include patient 
access, diagnosis, treatment, wellness and 
prevention, clinical information service, 
patient tracking (scheduling), consumables, 
and patient environment. These are 
currently being dissected and analyzed to 
engineer improved efficiency, and quality in 
a cost-effective environment for patients and 
physicians. 
Lastly, January saw many changes for us. 
Ambulatory Surgery began at the 17th & 
Chew site in new and re-designed operating 
rooms. 7A was resurrected to assist with the 
over-crowding of admissions in the 
emergency room while the ER is being re- ( 
engineered and re-configured to improve its 
functioning of care. Hospice opened its first 
inpatient unit at 17th & Chew. Mary Alice 
Czerwonka joined us in Public Relations, 
and Bob Laskowski began his first weeks as 
Senior Vice President of Clinical Services. 
Plans to complete the hospital-based skilled 
nursing facility at 17th & Chew, and the GI 
Lab and the Nephrology unit at Cedar Crest 
& I-78 are well underway. 
In my next communication, I hope to 
describe the revolution in hospitals known as 
patient centered care. I believe adoption of 
these principles will greatly· improve the 
efficiency and ease of caring for our patients 
in the near future. 
Sincerely, 
~ 
John E. Castaldo, M.D. 
President, Medical Staff 
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New Director of Telecommunications Named 
John G. Stoll, former Computer 
Operations Manager at Muhlenberg 
Ho8pital Center, has accepted the 
position of Director of 
Telecommunications, effective 
February 15. 
Mr. Stoll brings with him a wealth of 
experience which he gained in former 
positions at Pentamation Enterprises, 
Inc., Rite Aid Corporation, McCrory 
Stores, and as a principal in his 
consulting firm, John G. Stoll & 
Associates. 
News from Affinity 
• The Diabetic Foot and 
Comprehensive Wound Care Program 
officially opened on Monday, February 
13. Program hours are every Monday 
from 3 to 5 p.m. This 
multidisciplinary program is dedicated 
to the treatment and prevention of 
diabetic foot disease and wound care 
difficulties associated with the diabetic 
patient. 
• Affinity will begin offering Saturday 
hours starting March 4. Both 
Occupational Health and Rehabilitation 
Therapy services will be available. 
• Expanded hours are now available 
for Speech Pathology services. Adult 
and pediatric patients are both accepted 
for referrals by the speech pathologists. 
• Breath alcohol testing is now 
provided on a 24-hour basis. These 
studies conform to the new Department 
of Transportation and Federal Highway 
Administration regulations. 
In his new position, Mr. Stoll will be 
responsible for the telephone answering 
service, telephone and paging 
operators, pagers and cellular phones, 
and long distance services. 
Mr. Stoll will be located at 2024 
Lehigh Street; his telephone number is 
402-1801. 
For more information on any of these 
programs or to schedule a patient, 
please call Affinity at 402-9292. 
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Observation Level Policy 
The utilization of 1: 1 patient 
observation was recently examined by 
representatives from Nursing, 
Psychiatry, Neurology, and Geriatric 
Medicine due to its significant cost and 
utilization of resources. The cost of 
providing 1: 1 patient observation for 
this current fiscal year when annualized 
News from L VDI 
+ Lehigh Valley Diagnostic Imaging 
(LVDI) is pleased to announce the 
addition of a new diagnostic imaging 
modality. On January 3, L VDI began 
providing bone densitometry exams 
utilizing the most recent technology 
(Hologic QDR-1000 Plus Bone 
Densitometer). 
Bone densitometry procedures provide 
clinicians with bone mass measurements 
effective for the following clinical 
indications: 
• to aide in the detection and treatment of 
osteoporosis 
• to decide- about hormonal replacement 
therapy in estrogen deficient women 
• to adjust therapies of patients on long term 
glucocorticoids . _ 
• to decide about surgery in patients with 
asymptomatic primary hyperparathyroidism 
• to assess the efficacy of treatment therapies 
For more information about this 
procedure or to schedule an appointment, 
please call LVDI at 435-1600. 
Brochures explaining bone densitometry 
are available for both patients and 
physicians. Please call L VDI for a 
supply. (Please note: Patients are 
encouraged to verify coverage for this 
procedure with their insurance carrier.) 
will exceed $650,000. As a result, a { 
new policy which encompasses three 
different observation levels was 
developed and has been approved. The 
new policy, which will begin 
implementation on February 27, is 
attached to this newsletter for your 
information. 
+ L VDI is now a participating provider 
in the Prudential Health , Network 
including PruCare HMO, PruCare Plus, 
PruNetwork, and Prudential Plus. 
Members are encouraged to verify their 
eligibility for services prior to their 
radiology procedure. 
+ L VDI has recently upgraded its CT 
capabilities with a new General Electric 
helical (spiral) scanner. Helical scanneq 
are the latest advance in CT scanning · 
and provide several important 
advantages. The scanners are 
significantly faster allowing for greater 
patient. comfort and compliance. 
Further, since the data is acquired in a 
volume rather than individual slices, 
there is much less chance of missing 
small abnormalities and much greater 
reproducibility from scan to scan. These 
advantages are especially valuable in 
assessing the lungs and liver for 
metastases. The helical technique will 
be used in a great majority of 
examinations. 
+ LVDI has recently expanded its office 
hours. Current hours of operation are 7 
a.m. to 5:30p.m., Monday through 
Friday, and 8 a.m. to noon on Saturday. 
In addition, CAT scan and ultrasound 
appointments are available Tuesday and 
Thursday evenings until 8 p.m. ( 
Page4 
PHAMIS LastWord Classes for Physicians 
Following is the class schedule for 
PHAMIS LastWord training for 
physicians, residents, and allied health 
staff. All classes will be held in the 
Morgan Cancer Center training room, 
Suite 401 on the fourth floor. 
Tuesday, February 28 - 4 to 6 p.m. 
Thursday, March 9- 1 to 3 p.m. 
Wednesday, March 15 - 6 to 8 a.m. 
Wednesday, March 22- 4 to 6 p.m. 
Tuesday, April4- 6 to 8 a.m. 
Wednesday, April 12 - 1 to 3 p.m. 
Thursday, April 20- 4 to 6 p.m. 
Tuesday, May 9 - 1 to 3 p.m. 
Wednesday, May 17- 6 to 8 a.m. 
Thursday, May 25 - 4 to 6 p.m. 
Thursday, June 8 - 1 to 3 p.m. 
Wednesday, June 14- 4 to 6 p.m. 
Tuesday, June 20 ~ 6 to 8 a.m. · 
For more information or to register, 
contact Diann Brey in Information 
Services at 402-1404. 
Epilepsy Patients Needed for Study 
Lehigh Valley Hospital invites people 
with epilepsy to join a national 
research study on controlling seizures. 
The study will test Sabril, when taken 
with carbamazepine, a conventional 
epilepsy medicine commonly marketed 
as Tegretol. 
For the next 11 months, 360 patients, 
aged 18 and over, whose seizures are 
not completely controlled by 
carbamazepine, will take part in the 
study at 40 participating research sites 
in the United States. 
According to Alexander Rae-Grant, 
M.D., neurologist and the study's 
principal investigator at Lehigh Valley 
Hospital, for the first three months, 
subjects will take only carbamazepine 
to determine their monthly seizure rate. 
Subjects having one to four seizures 
per month will then receive either 
Sabri! or a placebo. Neither the 
patients nor the physicians treating 
them will know who is receiving which 
pill until the end of the study. 
During the study, participants will 
undergo a medical history and physical 
and neurologi:cal exams. Urine and 
blood samples will be analyzed to 
ensure proper levels of carbamazepine. 
Six times during the study, subjects 
will complete a quality of life 
questionnaire and a seizure severity 
assessment. They will also be asked t•; 
maintain a daily seizure calendar. 
After completing the required steps in 
the study, patients can continue in it, 
and they will be guaranteed to receive 
Sabri!. Those deciding not to continue: 
will have their study medication 
tapered off over a four-week period. 
Sabril is manufactured by Marion 
Merrell Dow, Inc., and has had 
extensive use in Europe and other 
clinical studies. 
For more information about the 
research study, call Joan Longenecker, 
research nurse, at 402-9830. 
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Research Advisory Committee - Request for Proposals 
{ 
The Research Advisory Committee 
(RAC) meets bi-monthly to review 
clinical/epidemiological research 
proposals (requests for funding) 
submitted by the Medical and 
Professional staff of Lehigh Valley 
Hospital. All proposals must be 
submitted to the Research Department 
for review three weeks before the next 
scheduled RAC meeting. 
The next meeting of the RAC is 
Thursday, April 20. All proposals 
submitted by March 31 will be 
reviewed by the Research Department 
before being placed on the RAC 
agenda. 
For more information or proposal 
guidelines, contact James F. Reed ill, 
Ph.D., Director of Research, at 
402-8889. 
Help Your Patients Stop Smoking 
The Coalition for a Smoke-Free Valley 
invites you to take part in its initiative 
to reduce smoking by offering you and 
your office staff training to help your 
patients stop smoking. 
As a physician, you know the health 
hazards of cigarette smoking and 
smokeless tobacco. It is the chief 
cause of preventable mortality in this 
country, responsible for more than 
434,000 deaths each year. You can 
play a vital role in reducing the 
number of smoking-related deaths by 
helping your patients stop smoking. 
Research has shown that your smoking 
cessation advice may provide the most 
critical incentive they have to stop. 
Your active involvement in smoking 
cessation counseling is particularly 
effective for many reasons, among 
them: 
• The physician/patient relationship in 
smoking cessation counseling is a unique 
and powerful one, giving you a natural 
forum for smoking cessation counseling. 
• More than 70% of U.S. smokers see 
their physician at least once a year, giving 
you access to more smokers than any other 
qualified individual, group or institution in 
our society. 
• Clinical trials have demonstrated the ( 
you can help your patients stop smoking. · 
How to Help Your Patients Stop 
. Smoking is a step-by-step guide for 
incorporating a smoking cessation 
program in your office developed by 
the National Cancer Institute. The 
guide employs a team approach to 
make maximum use of your time 
where it will be most effective, and to 
rely on your office staff for support · 
activities, without disrupting a busy 
practice. 
The training is free and only takes 
about one hour. For more information 
or to schedule a convenient time for 
your office to receive training in NCI's 
How to Help Your Patients Stop 
Smoking, contact Patti Sherwood, 
Training Coordinator, at the Coalition 





New books available at 17th & Chew 
include: 
Hales. The American Psychiatric 
Press Textbook of Psychiatry. 2nd 
ed. American Psychiatric Press, 1994. 
Schidlow. A Practical Guide to 
Pediatric Respiratory Diseases. 
Hanley & Belfus, 1994. 
Speroff. Clinical Gynecologic 
Endocrinology and Infertility. 5th 
ed. Williams & Wilkins, 1994. 
New acquisitions at Cedar Crest & 1-78 
which will help you to navigate the 
Internet include: 
Frey. !%(11:: A Directory of 
Electronic Mall Addressing the 
Networks. O'Reilly Assoc., 3rd ed., 
1993. 
News from the Pool Trust 
• The Dorothy Rider Pool Health Care 
Trust has awarded $5,000 to 
underwrite a community 
conference/workshop series to be 
spbnsored by the Chlldren's Coalition 
of the Lehigh Valley. The series, 
focused on children's issues, is 
designed to heighten public awareness 
of the need for systemic change, obtain 
commitments from funders and 
providers to assist change, develop 
strategies to implement six ambitious 
community goals, and assist providers 
and funders in understanding how they 
can reach those goals. 
The mission of the series is to 
preserve, create and promote 
comprehensive services which 
Levine. The Internet for Dummies. 
IDG Books Worldwide, 1993. 
Cronin. Doin& Business on the 
Internet. Van Nostrand· Reinhold, 
1994. 
Krol. The Whole Internet Catalog. 
O'Reilly Assoc., 1992. 
Dern. The Internet Guide for New 
Users. 1994. 
The following pocket guides are also 
available: 
v. 1 Telnetting; v. 2 Transferring 
Files; v. 3 Using and Navigating the 
Net; v. 4 E-Mail; v. 5 Basic Internet 
Utilities; and v. 6 Terminal 
Connections. 
empower every child and family to 
reach their full potential, and its 
purpose is to build a system that 
promotes healthy families who are able 
to adequately provide for their 
children's physical and emotional 
needs. 
• The Pool Trust has awarded $73,500 
in matching funds to support the 
ALERT Partnership's Alcohol, 
Tobacco and Other Drug (ATOD) 
Prevention Mini-Grant two-year 
program. 
ALERT-- Partnership for a Drug-Free 
Valley is a community prevention 
coalition in Lehigh and Northampton 
(Continued on Page 8) 
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Counties. Its mission is to prevent the 
illegal use and abJISe of alcohol, tobacco 
and other drugs in the Lehigh Valley 
through a unified community effort. 
Lehigh Valley Hospital serves as lead 
agency for the partnership. ALERT 
Partnership has over 160 members and 
employs community organizers who work 
on a neighborhood level to involve 
residents in addressing community 
problems. 
• The Pool Trust has awarded a one-year 
grant of $410,000 to Lehigh Valley 
Hospital (L VH) to plan the transformation 
of the hospital's education infrastructure 
and to support current education activities 
while this strategic planning takes place. 
Congratulations! 
Jerome C. Deutsch, DO, John F. 
McCarthy, DO, and William E. Zajdel, 
DO, Department of Emergency Medicine, 
recently passed the three-part certification 
process of the American Osteopathic Board 
of Emergency Medicine. 
Bruce A. Ellsweig, MD, Department of 
Family Practice, and WilHam E. Zajdel, 
DO, Department of Emergency Medicine, 
recently assumed the responsibilities of co-
medical directors of Cetronia Ambulance 
Corps. Dr. Ellsweig will focus on quality 
assurance and numerous employee health 
issues. Dr. Zajdel will have control of on-
line and off-line medical command as well · 
as advanced life support recertification and 
continuing education. 
Raymond A. Fritz, Jr., DPM, podiatrist, 
successfully completed the primary 
podiatric medicine certification 
examination of the American Board of 
Podiatric Orthopedics and Primary 
Podiatric Medicine and is now a Diplomate 
of the Board in that section. 
As with other Pool Trust grants, the 
ultiinate goal of this grant is to improve 
the health status of the Lehigh Valley 
region. It is hoped that grant will assist 
LVH in this goal by: (1) increasing LVH 
health professions education's focus on its 
impact on the health and well-being of the 
region, (2) strengthening the partnership 
between Penn State/Hershey Medical 
Center and L VH for allied health and 
medical education, particularly the . 
preparation of generalist physicians, (3) 
enhancing the continuing education 
opportunities for physicians, residents, 
medical students, nurses, and other health 
professionals throughout the region, and 
(4) increasing and integrating health 
services and outcomes research with 
applied health status improvement 
programs. 
Charles J. Incalcaterra, DMD, Assistant( 
Program Director, Department of 
Dentistry, was recently installed as 
President of the Lehigh Valley Dental 
Society at the annual dinner-dance. Other 
members of the Department of Dentistry 
who were installed as officers included: 
George F. Carr, DMD, Corresponding 
Secretary; Joel M. Gtickman, DMD, Vice 
President; George A. Kirchner, DDS, 
Second District Trustee; and Thomas J. 
McKee, DMD, Immediate Past President. 
Laura S. Kramer, DO, general internist, 
was informed by the American Board of 
Internal Medicine that she successfully 
passed the Geriatric Medicine examination. 
Anthony J. Magdatinski, DO, 
hematologist, was informed by the 
American Board of Internal Medicine at he 
successfully passed the Hematology 
examination and is now certified as a 
Diplomate in Hematology. 
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Papers, Publications and Presentations 
Henry H. Fetterman, MD, 
gynecologist, was a guest speaker at 
the American College of Obstetricians 
and Gynecologists District ill Annual 
District Meeting held November 9-12 
in Cancun, Mexico. Dr. Fetterman's 
topic was FaDed Tubal Ligation - The 
P.M.S.L.I.C. Experience. 
Peter A. Keblish, MD, chief, Division 
of Orthopedic Surgery, was an invited 
member of the faculty of the Tenth 
Annual Current Concepts in Total Joint 
Arthroplasty held in Orlando, Fla. 
The Current Concepts meeting is the 
largest of its kind in North America 
and attended by over 800 participants. 
Dr. Keblish gave a presentation on the 
study of the Patella, as well as a video 
presentation on the Lateral Approach in 
Valgus Total Knee Arthroplasty. 
In addition, Dr. Keblish was the 
principal author of the publication 
titled PateUa Resurfacing or 
Retention in Total Knee Arthroplasty 
- A Prospective Study of Patients 
with Bilateral Replacements which 
was published in the November 1994 
issue of The British Joumol of Bone 
and Joint Surgery. This study 
compares 52 resurfacing and non-
resurfacing in the same patient with 
long-term follow-up LCS Total Knee 
Replacement Arthroplasty. 
lndru T. Khubchandani, MD, colon 
and rectal surgeon, participated at a 
Wet Clinic at the University Hospital, 
Khatmandu, Nepal, in December. He 
performed repair of prolapse by 
perineal technique in three patients. 
In January, Dr. Khubchandani was a 
Visiting Professor at the Cleveland 
Clinic in Florida. He gave the Grand 
Rounds and made teaching rounds with 
the resident staff. He also assisted the 
residents in the operating room, 
demonstrating variation on 
performance of anorectal and colon 
procedures. 
Thomas D. Meade, MD, orthopedic 
surgeon, took home three first place 
medals in the freestyle and butterfly 
events from the Masters Swimming 
Invitational meet held recently in 
Boyertown, Pa. 
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The March Medical Staff/ 
Administrative Exchange Session will 
be held on Thursday, March 16, from 
5:30 to 7:30p.m., in Conference 
Room 1, Side B, of the John and 
Dorothy Morgan Cancer Center. 
The goal of the Exchange Sessions is 
to encourage the mutual exchange of 
information between members of the 
Medical Staff and senior management 
in an informal, relaxed atmosphere. 
As space is limited to 40 people, 
registration will be taken on a first-
come, first-serve basis. 
For more information or to register, 
please contact Janet M. Seifert in 
Physician Relations at 402'-9853. 
Stabler-Rex Health Care 
Symposium 
The third annual Stabler-Rex HeaHh 
Care Symposium titled Medicine: 
Year 2001 will be held on Saturday, 
March 18, from 8:30a.m. to 1 p.m., 
in the Auditorium of Lehigh Valley 
Hospital, Cedar Crest & 1-78. 
Speakers include Dennis Palkon, 
Ph.D., Chairman and Associate 
Professor, Department of Health 
Administration at Florida Atlantic 
University; Walter Harry Caulfield, 
Jr., M.D., Executive Director of the 
Permanente Medical Group in 
Oakland, Calif.; and Col. Richard 
Satava, M.D., Associate Clinical 
Professor of Surgery, Walter Reed 
Army Medical·Center and Special 
Assistant, Advanced Biomedical 
Technology, U.S. Army. 
The topics to be discussed include 
Medical Megatrends, Health ·care 
Revolution: The California Experience, 
and Robotics, Virtual Reality, and 
Telepresent Surgery for the Future of 
Medicine. 
Members of the community concerned 
with the future of health care, its 
administration, funding, and 
technology are invited to attend. The 
symposium is sponsored by the Dr. 
John E. Stahler and the Dr. James C. 
Rex Endowment Fund in Support of 
Surgical Education, Research, and 
Development. 
For more information, contact the 
Department of Surgery at 402-1296. 
Regional Symposium 
Series VI 
Fifth Annual Critical Care 
Symposium will be held on Friday, 
February 24, from 7:20 a.m. to 12:15 
p.m., in the Auditorium of Lehigh 
Valley Hospital, Cedar Crest & 1-78. 
Physicians, nurses, and other health 
care professionals interested in an 
update in critical care medicine will 
benefit from the program. 
(Continued on Page 1 1) 
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At the completion of the program, 
participants should be able to: 
• discuss diagnosis of pulmonary · 
thromboembolic disease and the role of 
low molecular weight heparin in 
prevention and treatment 
• describe the developments leading to 
limited critical care services and 
methods for limiting care 
• explain the diagnosis and most 
current treatment of candida in surgical 
patients 
• describe various treatment modalities 
for patients with ventilator-associated 
pneumonia. 
Neuropsychiatry: Current Topics 
will be held on Friday, March 3, from 
8 a.m. to 12:30 p.m., in the 
Auditorium of Lehigh Valley Hospital, 
Cedar Crest & I-78. 
Physicians, nurses, psychologists, 
social workers, and other mental health 
professionals interested in current 
topics of neuropsychiatry will benefit 
from this program. 
At the completion of the program, 
participants should be able to: 
• describe the clinical approach to 
identification and treatment of post-
stroke depression and the influence of 
post-stroke depression on long term 
rehabilitation 
e describe the effect of psychosocial 
factors on post-stroke depression 
• describe the clinical attributes of 
subcortical brain dysfunction and a 
screening tool used to identify them 
• describe the neuro-physiology of 
post-traumatic stress disorder as it 
relates to sleep disturbances. 
.Sixth Annu81 Infectious Diseases 
Symposium: HIV Issues will be held 
on Thursday, March 16, from 12:30 to 
4:30 p.m., in the Auditorium of 
Lehigh Valley Hospital, Cedar Crest & 
1-78. 
Primary care physicians, infectious 
diseases physicians, obstetricians, 
gynecologists, dentists, nurses and 
other health care professionals 
concerned with infectious diseases will 
benefit from the program. 
At the completion of the program, the 
participant should be able to: 
• describe the oral manifestations 
commonly associated with HIV 
• describe the current management and 
treatment of pregnancy I gynecological 
problems in HIV positive women 
• explain the importance of nutrition 
for individuals with HIV. 
For more information on the above 
programs, please contact Human 
Resource Development at 402-1210. 
Department of Pediatrics 
Common Pediatric Urological 
Problems with Emphasis on Prenatal 
Diagnoses and Renal Abnormalities 
and Urinary Tract Infections -
Recommendations for Evaluations 
will be presented by Ross Deeter, 
M.D., pediatric urologist, Hershey 
Medical Center, on Friday, February 
24, at noon in the Auditorium of 
Lehigh Valley Hospital, 17th & Chew. 
For more information, contact Beverly 
Humphrey in the Department of 
Pediatrics at 402-2410. 
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Health Promotion and Disease Prevention News 
· Sinfully Delightful Desserts, a free 
public lecture presented by the Health 
Promotion and Disease Prevention 
Department, will be held on Tuesday, 
March 14, from 7 to 8:30 p.m., in the 
Auditorium of Lehigh Valley Hospital, 
Cedar Crest & 1-78. 
Discover how you really can have your 
cake and eat it too! With both Easter 
and Passover just around the comer, 
get ideas for lighter versions of your 
favorite holiday sweets. Dietitians 
Sandra Barillo and Marcia Richards 
will instruct participants how to choose 
"safe" desserts, and prepare samples of 
these scrumptious "forbidden" foods. 
In addition to free public lectures, the 
Health Promotion and Disease 
Prevention Department offers 
numerous classes and programs which 
may benefit your patients. 
Some of these include: 
• Nutrition and Stress ~minar -
Tuesday, March 7, from 7 to 9 p.m., 
1243 S. Cedar Crest Blvd., Third 
Floor Conference Room. 
While stress is present in our everyday 
lives, sometimes it becomes 
overwhelming. Fortunately, proper 
diet and exercise can help to reduce the 
deleterious effects stress has on our 
bodies. A registered dietitian will 
cover nutrition and how our bodies 
react to stress, while an exercise 
specialist will review how physical 
activity improves our body's ability to 
respond to stress. Participants will 
learn what specific nutrition 
modifications and relaxing exercises 
can help them feel better. 
• QuitSmart - Developed at Duke 
University, this program combines 
flexibility, simplicity, and SUCCESS. 
Using self-hypnosis and the BetterQuit 
Cigarette Substitute, participants 
achieve abstinence and urge control 
through a five session program. The 
six month success rate averages 61%, 
with significant tobacco reduction 
occurring in 65% of participants. 
This five-session program will begin 
on Monday, March 6, from 7 to 8 
p.m., in the Morgan Cancer Center, 
Classroom lB. 
• Aerobic and Conditioning Classes 
for Adults - Cross training is one of 
· the most powerful techniques to 
achieve optimal health and fitness 
benefits. Adjustable steps, lateral 
motion slides, and resistance tubing ai'1' 
used for aerobic, strength and · 
flexibility training. More than 60 
weekly classes are offered at different 
Lehigh Valley locations. 
These and many other programs for 
nutrition and weight control, stress 
management, fitness, and nicotine 
dependence services are available 
through the Health Promotion and 
Disease Prevention Department of 
Lehigh Valley Hospital. 
For information on any of these 
programs, contact the Health 
Promotion and Disease Prevention 
Department at 402-5960. 
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WHO'S NEW 
The Who's New section of Medical 
Stqff Progress Notes contains an 
update of new appointments, address 
changes, newly approved privileges, 
etc. Please remember that each 
department or unit is responsible for 
updating its directory, rolodexes, and 
approved privilege rosters. 
Medical Staff 
Appointment 
Adrienne E. Apatoczky, DO 
Cedar Crest Emergicenter 
(David I. Shingles, DO) 
1101 S. Cedar Crest Blvd. 
Allentown, PA 18103-7937 
(610) 433-4260 
Change of Status 
Stephen M. Purcell, DO 
Department of Medicine 
Division of Dermatology 
From Consulting to Provisional Active 
Wendy Rosh-Spinosa, MD 
Department of Family Practice 
From Courtesy to Provisional Active 
Additional Privileges 
James A. Sandberg, MD 
Department of Medicine 
Division of Cardiology 
Active 
Insert Permanent Pacemakers 
Address Changes 
Chris C.N. Chang, MD 
401 N. 17th Street 
Suite 206 
Allentown, PA 18104-5050 
Joseph J. Grassi, MD 
1101 S. Cedar Crest Blvd. 
Second Floor 
Allentown, PA 18103 
General Surgical Associates 
Richard C. Boorse, M.D. 
Mark A. Gittleman, M.D. 
George W. Hartzell, Jr., M.D .. 
Douglas R. Trostle, M.D. 
1240 S. Cedar Crest Blvd. 
Suite 208 
Allentown, PA 18103 
Telephone/Fax Number 
Changes 
Michael B. Heller, MD 
(610) 954-9403 
. FAX: (610) 954-4979 
Elliot J. Sussman, MD 
(610) 402-7500 
FAX: (610) 402-7523 
Douglas A. Tozzoll, DPM 
FAX: (610) 432-4887 
Resignations 
Robert J. Echenberg, MD 
Department of Obstetrics and 
Gynecology 
Division of Primary OBGYN 
Provisional Active 
(Continued on Page 14t 
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(Continued from Page 13) 
Marpret McHugh, MD 
Department of Emergency Medicine 





Georgette M. Guth, RN 
Physician Extender 
Professional - RN 
(Valley Oral Surgery- Dr. Popowich) 
Sandra Vitello, PNP 
Physician Extender 
Professional - PNP 
(Hospital -Pediatric Clinic) 
Additional Privileges 
Ellen Fain:hild, PNP 
Susan Bolecz, PNP 
Lora Lesik, PNP 
Pamela Prisaznik, PNP 
Sandra Vitello, PNP 
Physician Extender 
Professional - PNP 
(Hospital -Pediatrics) 
Addition of Category 3 Privileges -
Inpatient Care Newborn Infants 
Class A - Normal Newborns more than 





A Service of lniiSHVAILEY 
HOSPrn\L 
C-Reactive Protein: An Introduction to the 
Underutilized Forgotten Test 
The acute phase response is the 
medical term to describe the systemic 
response of the body to local tissue 
damage and especially inflammation. 
Included in this syndrome is fever and 
neutrophil leukocytosis with a rapid 
increased concentration of specific 
proteins. 
CRP is the most striking acute phase 
reactant that dates back to 1930. It 
was identified as one of a highly 
heterogeneous group of proteins that 
formed a complex with C-
polysaccharide of the pneumococcus. 
It has an unusual structure being one 
of two pentraxins in serum with a 
cyclicpentameric protein structure. 
CRP is synthesized only by hepatocytes 
surrounding the portal tract and then 
spreading outward in response to 
inflammation. Possibly interleukin-1 
(IL-l) is the primary agent for the 
humoral stimulus. The role of CRP is 
unknown but neutrophil proteases 
cleave CRP producing peptides with 
immuno-modulating action. Since CRP 
binds chromatin it may act to scavenge 
chromatin during cell death. 
As an acute phase reactant CRP 
exhibits two distinct advantages. First, 
the serum concentration can increase 
several fold (even up to 1,000 times) in 
response to tissue injury or 
inflammation. Secondly, it is 
distinguished by its rapid rise in 
response (within 4-6 hours) to injury or 
inflammation. Other acute phase 
reactants may take up to 24 hours to 
produce a detectable signal in serum. 
CRP was first measured by an (at best) 
semi quantitative agglutination method 
with results reported as serial dilutions. 
With this methodology it is easy to 
understand that measuring leukocytes 
or erythrocyte sedimentation rate 
(ESR) was less subjective and more 
clinically diagnostic. However, CRP 
is currently quantitated by a 
sophisticated nephelometric 
measurement which can be provided on 
a STAT basis 24 hours/day. Currently 
we do not offer this test STAT as there 
has not been any demand for this 
service. 
Health Network Laboratories can easily 
institute a STAT test method with a 
change in clinical ordering 
requirements. The March Newsletter 
will summarize literature references 
that detail the specific utility of CRP 
for several disease conditions. 
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As a general summary, CRP is the best 
surrogate test for infectious disease. 
Research papers suggest that CRP is 
essential for good patient care. While 
a negative result eliminates a large 
number of inflammatory conditions and 
predicts a better prognosis for the 
patient, a high level confirms the 
presence of an acute inflammatory 
condition and supports consideration of 
a more aggressive therapeutic action 
and treatment. The predictive value of 
a negative result is greater than 95% . 
Finally, it is worth noting that the 
Cleveland Clinic recommends CRP 
over the ESR test in a number of . 
clinical situations. For the detection o~ 
occult infection and/or tissue injury 
clearly CRP is more sensitive and 
specific than the ESR test. 
David. G. Beckwith, Ph.D. 
Vice President, Operations 
Clinical Laboratories 






P & T HIGHLIGHTS· 
The following action were taken at the January 9, 1995 Pharmacy and 
Therapeutics Committee Meeting- Maria Barr, Pharm.D., Barbara Leri, Pharm.D., 
Richard Townsend, R.Ph. 
FORMULARY ADDITIONS 
OUT WITH THE OLD - IN WITH 
THE NEW! 
Glyburide Micronized (Glynase, Upjohn), a 
unique formulation of glyburide, was added 
to the formulary based on the increasing use 
of this agent. An advantage of glyburide 
micronized is a more consistent 24 hour 
glucose control. Disadvantages are the cost 
and lack of equivalent dosage conversion 
data between glyburide micronized and 
glyburide non-micronized. A class review 
of all the oral sulfonylurea agents was 
performed by the Pharmacy Department in 
conjunction with the Endocrine Division. 
All first generation sulfonylureas including 
acetohexamide (Dymelor-R), chlorpropamide 
(Diabinese), tolazamide (TolinaseR), and 
tolbutamide (OrinaseR) will be deleted from 
the formulary due to low use and adverse 
effect profile. The newer more widely used 
second generation agents such as glypizide 
(GlucatrolR), and glyburide (Diabe.taR, 
Micronase) will remain on formulary as 
first-line agents for oral glucose control. 
DUE CORNER 
Ondansetron 
The ondansetron automatic substitution for 
standard parenteral dosing (See Table 1) was 
instituted last November, 1994. 
Table I: 
Lehigh Valley Hospital Ondansetron 
Automatic Substitution Policy 
Dose Ordered Previous Dose Current Dose 
Dispensed Dispensed 
< Smg Dose ordered 4mg 
> Smg &. < 12mg 10mg 8mg 
> 12mg &. < 20mg Dose ordered 16mg 
> 20mg &. < 28mg Dose ordered 24mg 
> 28mg 32mg 32mg 
December data on 23 orders was reviewed 
for number of doses ordered, number 
automatically substituted according to the 
policy, and the cost savings associated with 
each change~ Total savings for the month 
was $1,078.80. Continued efforts are being 
focused on education. 
Target Antimicrobial Agents 
Target agents monitored on a daily basis 
include ceftazidime, IV ciprofloxacin, 
ampicillinlsulbactam, and IV fluconazole. 
A summary of key points from November, 
1994 along with changes in expenditures 










Agent Use in Changes 
Dollars for YTD 
Nov/94 93/94 ($) 
Ceftazidime $12,639 • 33,902 
IV Ciprofloxacin $ 7,557 no change 
Ampicillin!Sulbactam $7,249 • 32,685 
c IV Fluconazole $6,958 t 40,000 
* Tar et len tth ot empmc anUbtoUc therapy ts 3 days •• g g 
TPA Usage Report 
Fou$ quarter 1994 data on TP A usage in 
32 patients was presented. To date, 161 
patients receiving thrombolytic therapy have 
been evaluated for dosage administration 
regimen and safety. All patients received 
TPA. No streptokinase was utilized. The 
standard dosing regimen which administers 
the total dose over 3 hours was used in 65% 
of TP A cases during the evaluation period 
from March 1993 to present. During this 
same period, 35% of cases received TP A by 
the accelerated or "front-loaded" regimen 
which delivers the total dose over 1.5 hours. 
No serious adverse clinical events were 
observed during the fourth quarter. 
Thrombolytic monitoring will continue with 
quarterly reports. Preprinted acute 
myocardial infarction thrombolytic order 





3.4 days* 80% of use is 1Gm vs 2Gm 
3.3 days* 80% are being converted to PO 
3.0 days* - 2 orders were received for 
penicillin allergic patients 
-use in pneumonia other than 
aspiration has decreased 
-use in colorectal surgical 
prophylaxis has increased; use of 
alternative agents such as cefazolin 
plus metronidazole or cefotetan are 
encouraged 
8.3 days** 75-100% are being converted to PO 
arget length o · tlucooazole empmc therapy to be determl ned 
IV Diltiazem (Cardium) Usage Evaluation: 
Let's Stick to the Criteria! 
A second review of diltiazem injection use 
since it's addition to the formulary in 
January, 1994 was performed to review 
adherence to the approved criteria. 
Diltiazem injection was approved as a 
second-line agent to verapamil in patients 
who meet one of the following criteria: 
1. Failure of I. V. verapamil. 
Failure defined as inadequate HR control after a total 
cumulative IVP verapamil dose of 20mg followed by 
a continuous infusion of verapamil 1 Omg/hr x 1 hour. 
2. And/or Intolerance to a 5mg I.V. verapamil dose 
defined as: 
a. A decrease in systolic blood pressure of lOmmHg 
from baseline or < 90mmHg and symptomatic. 
OR 
b. New onset or worsening CHF signs and 
symptoms. 
OR 
c. Documented allergy to verapamil HCL 
3. A baseline symptomatic hypotension < 90mmHg 
requiring pressor agents or, EF ~ 35% and/or 





IV Diltiazem was used in 64 patients during 
1994. Verapamil remained consistent with 
use in 79 patients over the same time 
period. 57 of the 64 patients (89%) met the 
criteria for use. Of the 7 patients not 
meeting the criteria, 2 failed diltiazem for 
HR control and where subsequently changed 
to verapamil with success; 3 patients with 
stable hemodynamics received dilti~em 
first-line without a verapamil trial; 1 patient 
was treated with diltiazem for hypertension 
without effect; and 1 patient given diltiazem 
as first-line therapy for atrial fibrillation 
developed a transient junctional bradycardia. 
Symptomatic hypotension requtnng 
discontinuation of diltiazem occurred in 5 
patients (7. 8%) to date. IV diltiazem will 
continue to be monitored . for use in 
accordance with the approved criteria. 
Those physicians ordering IV diltiazem for 
use in patients not meeting the usage criteria 
will recei~e written communication via a 
representative from the Pharmacy and 
Therapeutics Committee. 
Update on Vancomycin 
Serum Levels: No More 
Peaks and Troughs! 
In May 1994, an educational campaign was 
undertaken to enhance appropriateness and 
decrease unnecessary serum vancomycin 
monitoring. Vancomycin levels should not 
be routinely . done in patients with normal 
renal function and susceptible organisms. 
Vancomycin trough levels may be useful 
(but NOT mandatory) in the following 
situations: 
1. Patients receiving combination therapy with other 
nephrotoxic agents i.e. vancomycin + an 
aminoglycoside (gentamicin, tobramycin, or 
amikacin). 
2. Patients on hemodialysis to aid in determining time 
for next dose (usual adult dose is lGm weekly). 
3. Patients in higher than usual doses of vancomycin 
being given for resistant or CNS infection. 
4. Patients with rapidly changing renal function. 
The number of vancomycin levels performed 
before and after the educational effort were 
monitored. Through December 1994, a 
51.8% decrease in the number of 
vancomycin levels performed was noted. 
The amount of vancomycin used during this 
time period remained consistent. Based on 
this information, a $31,706.90 annualized 
laboratory savings is anticipated. A 
continued concerted effort needs to be made 
to assure unnecessary vancomycin levels are 
avoided. 
PCA/Epidural Guidelines 
The Committee approved guidelines with the 
usual dosage ranges of commonly prescribed 
patient controlled analgesia and epidural 
medications for addition to the nursing IV 
guidelines to serve as a reference tool. The 
guidelines were reviewed and doses verified 
by the Pain Management and Anesthesia 
Department representatives. 
FYI 
Drug Unavailability: We Want But 
Can't Have! 
A nationwide shortage of albumin, 
pneumococcal vaccine and scopolamine 
transdermal patches are being experienced. 
A multidisciplinary group is presently 
working on the development of housewide 
guidelines for use for albumin. In the 
interim, physicians are asked to consider 
crystalloids, or hetastarch if colloidal 
therapy is required, prior to using albumin. 
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Pneumococcal vaccine is available in limited 
supply for inpatient use. Transdennal 
scopolamine is not expected to be 
reavailable until 3rd quarter 1995. 
Physicians are asked to consider alternative 
agents during this time period. 
Daily Standard Dosing Time 
Clarification: 
Remember 0900 = QD = Q24H 
Presently all medications ·ordered to be 
given daily are given at 0900 according to 
the standard dosing time policy. 
Medications ordered every 24 hours will 
also be given at 0900 according to this 
policy. 
pt\1199S.hi 
Warfarin Sliding Scale Pilot: Keep 
your Fingers Crossed for Success 
Beginning February 1, 1995, 5C will be 
piloting a warfarin sliding scale in a select 
orthopedic population. The pilot will 
include monitoring for efficacy and adverse 
effects. Housewide expansion of use of the 
warfarin sliding scale will be addressed after 
the results of the 5C pilot are reviewed. 
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SELF-ASSESSMENT TEST FOR STAFF PHYSICIANS 
(Assembled by the CME Subcommittee after discussions with the Legal 
Department and Research Department about their concerns. Answers are 
found on page 22). 
First, a couple of warm-up questions: 
1 . The use of FDA approved drugs for non-approved indications is allowed 
only after approval from an Institutional Review Board (IRB). 
a. yes 
b. no 
2. An attending physician or resident must disclose to the patient and get 




The use of Phase II and Phase Ill drug trials and/or the implantation or use of 
any experimental devices requires the approval of our IRB. 
3. At the present time, how many of such research protocol are active with 
our IRB by members of the staff: 
a. 25 to 125 
b. 125 to 250 
c. 250 to 300 
The manufacturers of experimental devices or drugs are referred to as 
"sponsors" and must be approved by the· FDA. Staff physicians employing 
these drugs or devices are called "investigators." 
4. An investigator must maintain accurate, complete, and current records as 
relate to the following: (true or false) 
a. all correspondence with another investigator, an IRB, the FDA, and 
the sponsor 
b. type, quantity, dates of receipt, and code or batch numbers of 
devices or drugs 
c. names of all persons receiving the device or drug 
d. documents evidencing informed consent 
e. all relevant observations, adverse effects, condition of each subject 
entering and during course of investigation, relevant past medical 
history, and results of all diagnostic tests. 
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5. For unanticipated adverse effects, the investigator is required to submit 
a report within 1 0 days to: 
a. the lAB ( 
b. the sponsor 
c. the FDA 
d. the President of the Medical Staff 
6. In the event of a withdrawal of approval by our lAB, the investigator: 
a. must report to the sponsor within 5 days 
b. must report to the FDA 
c. can continue the research if they get approval from another hospital's 
lAB 
7. The investigator must submit progress reports no less often than yearly 
to: 
a. the CEO of the hospital 
b. the FDA 
c. the sponsor 
d. the lAB 
8. An investigator must submit his/her FINAL REPORT within 3 months after 
termination or completion to: 
a. the FDA 
b. the sponsor 
c. an lAB 
9. If our lAB considers a device or drug to pose a significant risk and the 
sponsor had proposed the device or drug not to be, the sponsor must: 
a. seek another hospital for its investigations 
b. report our lAB's determination to the FDA within 5 working days 
(A copy of the current regulations, along with an excellent discussion on them, 






SUBJECT: Observation Levels 
EFFECTIVE DATE: 
AREAS AFFECTED: 
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I. POLICY 
A level of observation may be ordered by a physician when a patient 
requires close and/or continuous visual monitoring. The following 
procedures will be implemented when managing a patient requiring 
specific levels of observation. 
II. SCOPE 
III. 
All hospital employees, students & medical staff. 
DEFIRITIORS 
A. Close observation (Arms' Length) - This level of observation is the 
most intensive level and requires that the patient be within arm's 
reach of an assigned staff member at all times. A physician or 
other staff member, while examining the patient, can accept this 
responsibility. However, the assigned staff member must remain 
immediately outside the examination area. 
B. Visual observation - This level of observation requires that a 
staff member be within eye contact of an assigned patient at all 
times. The assigned staff person can be observing more than one 
patient at a time. The assigned staff person will be able to 
perform other duties as long as the patient at risk is in eye 
contact at all times. A physician or other staff member, while 
examining the patient, can accept this responsibility. 
c. 15 minute observations - This level of observation requires that 




A. If a physician orders 1:1 
observation, a clarification 
indicating close or visual 
observation must be obtained. 
B. A physician's order is needed 
for observation status. If it 
is in the best interest of the 
patient, the nurse may place a 
patient on an observation level 
for a brief period of time not to 
exceed 8 hours, until a MD 
order is obtained. The physician 
must document the reason for the 






c. When an observation level is ordered 
for suicide precautions, an order 
for psychiatric consultation must 
be placed for patient evaluation 
concurrent with the observation 
order. 
D. When an observation level is 
ordered for patients with 
intermittent, situational 
or continuous confusion, an order 
for psychiatric, geriatric or 
neurologic consultation is recommended 
within 24° for patient evaluation and 
development of alternative modes of 
patient management. 
E. The physician must review the 
order for observation every 24° 
and rewrite the order if the 
observation level is to be 
continued. 
F. Alternative mechanisms of achieving a 
high level of observation must be 
explored. 
1. If observation is ordered for 
a patient in a critical care 
area, the staffing assignments 
should be examined to determine 
if an RN can have the· patient 
requiring observation as their 
only patient assignment. 
2. If visual observation is ordered, 
the placement of 2 observation 
patients in one semi-private room 
or placement of a patient in· a 4 
bed room may be possible. This may 
require unit transfer to achieve 
this efficiency. 
3. Assess for appropriate use of 
restraints. 
4. Assess for appropriate use of seclusion 
on Psychiatric Units. 
5. Involve families in care of patient. 
6. Determine if placement of patient 
close to the nurse's station would 
be beneficial. 
7. Other creative strategies to 
achieve observational efficiency 
should be explored. 










F. Health care team members will refer to 
the appropriate policies for specific 
process and clinical information. 
1. Self-Injury Behavior, Patients at 
Risk - Medical/Surgical Clinical 
Policy and Procedure Manual 
2. Risk for Self Injury Behavior -








PAGE: 3 of 3 
Physician 







Cedar Crest & 1-78 
P.O. Box 689 
Allentown, PA 18105-1556 
Mldical Sto/f 
Progress Notes 
John E. Castaldo, M.D. 
President, Medical Staff 
Robert X. Murphy, Jr., M.D. 
President-elect, Medical Staff 
Joseph A. Candio, M.D. 
Past President, Medical Staff 
John W. Hart 
Vice President 
Rita M. Mest , 
Medical Staff Coordinator 
Janet M. Seifert 
Physician Relations 
Managing Editor 
Richard C. Boono, M.D. 
Jo~eph A. Candio, M.D. 
John B. Caltaldo, M.D. 
Robert V. CuiDIIIillaa, M.D. 
Robert B. Doll, M.D. 
John D. Fanell, M.D. 
John P. Pitzat'bboaa, M.D. 
Paul Guillud, M.D. 
Tb.omu A. Hutchinaon, M.D. 
Jamea W. Jaft'e, M.D. 
Jay H. Kautioan, M.D. 
Micbaol W. Kautmann, M.D. 
Robert J. Laalwwati, M.D. 
Mark C. Loator, M.D. 
R.oaald A. Lutz, M.D. 
AlphOIIIO A. Matteo, M.D. 
Robert X. Murphy, Jr., M.D. 
Walter J. Okunaki, M.D. 
Mark A. Ollbome, M.D. 
Victor R.. Ritch, M.D. 
R.aDdy A. R.oaen, M.D. 
NormanS. Sarachek, M.D. 
John J. Shane, M.D. 
Elliot J. SUIIIIIIIl, M.D. 
Jobn D. VanBrakle, M.D. 
Headley S. White, M.D. 
Geary L. Yeialey, M.D. 





Permit No. 1922 
,..,. SIII/I,.,... .. 
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